Table 1 Correlation analyses between CREB5 and clinical parameters.
From: CREB5 promotes nodal metastasis of cervical cancer by regulation of APLN-induced lymphangiogenesis
Variables | Total | CREB5 expression | P value | |
|---|---|---|---|---|
123 | Low | High | ||
Age | Â | Â | Â | 0.284 |
 < 42 | 33 | 17 | 16 |  |
 ≥ 42 | 90 | 56 | 34 |  |
FIGO stage | Â | Â | Â | 0.196 |
 I (IA2 + IB1 + IB2) | 98 | 61 | 37 |  |
 II (IIA1 + IIA2) | 25 | 12 | 13 |  |
Tumor Size | Â | Â | Â | 0.508 |
 ≤ 4 cm | 112 | 68 | 44 |  |
 > 4 cm | 11 | 5 | 6 |  |
Histopathologic types | Â | Â | Â | 0.179a |
 Squamous cell carcinoma | 108 | 62 | 46 |  |
 Adenocarcinoma | 9 | 8 | 1 |  |
 Adenosquamous carcinoma | 6 | 3 | 3 |  |
Differentiation | Â | Â | Â | 0.678a |
 High | 1 | 1 | 0 |  |
 Medium | 52 | 33 | 19 |  |
 Low | 70 | 39 | 31 |  |
Stromal invasion | Â | Â | Â | 0.115 |
 < 1/2 | 42 | 29 | 13 |  |
 ≥ 1/2 | 81 | 44 | 37 |  |
LVSI | Â | Â | Â | <0.001 |
 Positive | 51 | 4 | 47 |  |
 Negative | 72 | 69 | 3 |  |
LNM | Â | Â | Â | <0.001 |
 Positive | 26 | 7 | 19 |  |
 Negative | 97 | 66 | 31 |  |